Gene ID | Gene Name | Gene Symbol | Disease Ontology ▲ |
---|---|---|---|
101478170 | beta-1,4-N-acetyl-galactosaminyl transferase 1b |
|
|
101482941 | fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
|
101486948 | dpy-19 like 4 |
|
|
101477014 | UDP-glucose glycoprotein glucosyltransferase 2 |
|
|
101475363 | carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14 |
|
|
101479093 | ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
|
|
101481280 | polypeptide N-acetylgalactosaminyltransferase 10 |
|
|
101486534 | beta 3-glucosyltransferase a |
|
|
101465741 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 |
|
|
101478600 | UDP-glucuronosyltransferase 2C1 |
|
|
101475990 | fucosyltransferase 9a |
|
|
101465046 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
|
|
101466910 | ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
|
|
101484572 | carbohydrate sulfotransferase 2 |
|
|
101481391 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 |
|
|
101480254 | LARGE xylosyl- and glucuronyltransferase 2 |
|
|
101476334 | protein O-fucosyltransferase 2 |
|
|
101481338 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11 (GalNAc-T11) |
|
|
101467932 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2-like |
|
|
105941471 | beta-1,4 N-acetylgalactosaminyltransferase 2 |
|
|
101466082 | mannose-P-dolichol utilization defect 1 protein |
|
|
101480939 | glycogenin-1 |
|
|
101470803 | alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase a |
|
|
101472320 | DP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, like |
|
|
101475602 | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024